Vaccinex (VCNX) Competitors $0.70 -0.28 (-28.57%) As of 02:19 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. CYCN, BFRI, ADXN, MYNZ, RNAZ, OMGA, INDP, AIM, APLM, and SLXNShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Cyclerion Therapeutics (CYCN), Biofrontera (BFRI), Addex Therapeutics (ADXN), Mainz Biomed (MYNZ), TransCode Therapeutics (RNAZ), Omega Therapeutics (OMGA), Indaptus Therapeutics (INDP), AIM ImmunoTech (AIM), Apollomics (APLM), and Silexion Therapeutics (SLXN). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Cyclerion Therapeutics Biofrontera Addex Therapeutics Mainz Biomed TransCode Therapeutics Omega Therapeutics Indaptus Therapeutics AIM ImmunoTech Apollomics Silexion Therapeutics Vaccinex (NASDAQ:VCNX) and Cyclerion Therapeutics (NASDAQ:CYCN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, community ranking, dividends, analyst recommendations, profitability, earnings, valuation and risk. Does the media prefer VCNX or CYCN? In the previous week, Cyclerion Therapeutics had 1 more articles in the media than Vaccinex. MarketBeat recorded 1 mentions for Cyclerion Therapeutics and 0 mentions for Vaccinex. Cyclerion Therapeutics' average media sentiment score of 1.89 beat Vaccinex's score of 0.00 indicating that Cyclerion Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Vaccinex Neutral Cyclerion Therapeutics Very Positive Does the MarketBeat Community prefer VCNX or CYCN? Vaccinex received 89 more outperform votes than Cyclerion Therapeutics when rated by MarketBeat users. Likewise, 60.00% of users gave Vaccinex an outperform vote while only 58.62% of users gave Cyclerion Therapeutics an outperform vote. CompanyUnderperformOutperformVaccinexOutperform Votes12360.00% Underperform Votes8240.00% Cyclerion TherapeuticsOutperform Votes3458.62% Underperform Votes2441.38% Do institutionals & insiders believe in VCNX or CYCN? 50.1% of Vaccinex shares are owned by institutional investors. Comparatively, 75.6% of Cyclerion Therapeutics shares are owned by institutional investors. 51.5% of Vaccinex shares are owned by insiders. Comparatively, 36.1% of Cyclerion Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has higher earnings & valuation, VCNX or CYCN? Cyclerion Therapeutics has higher revenue and earnings than Vaccinex. Cyclerion Therapeutics is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K6.57-$20.25M-$48.27-0.02Cyclerion Therapeutics$2M4.43-$5.26M-$1.22-2.68 Which has more risk and volatility, VCNX or CYCN? Vaccinex has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Cyclerion Therapeutics has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500. Is VCNX or CYCN more profitable? Vaccinex's return on equity of 0.00% beat Cyclerion Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Cyclerion Therapeutics N/A -55.32%-48.35% SummaryCyclerion Therapeutics beats Vaccinex on 8 of the 14 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.55M$6.85B$5.54B$7.93BDividend YieldN/A2.95%5.09%4.23%P/E Ratio-0.027.3222.6018.55Price / Sales6.57241.43400.01103.29Price / CashN/A65.8538.1834.62Price / Book-0.386.486.774.25Net Income-$20.25M$143.41M$3.22B$248.18M7 Day Performance8.88%1.91%1.10%0.91%1 Month Performance-2.00%4.28%2.48%2.58%1 Year Performance-84.14%-3.87%15.71%4.02% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinexN/A$0.70-28.6%N/A-84.1%$1.82M$388,000.00-0.0140Gap UpCYCNCyclerion Therapeutics1.8347 of 5 stars$2.70-1.8%N/A+14.3%$7.32M$2M-2.2130Upcoming EarningsPositive NewsBFRIBiofrontera2.7962 of 5 stars$0.81-4.7%$7.00+764.2%-64.8%$7.19M$37.32M-0.3670News CoverageGap DownADXNAddex Therapeutics2.3704 of 5 stars$6.75-10.0%$30.00+344.4%-0.2%$7.16M$556,045.00-19.8530Short Interest ↓Gap DownMYNZMainz Biomed2.9899 of 5 stars$3.07-4.7%$14.00+356.0%-90.3%$7.12M$893,991.00-0.0530Gap UpRNAZTransCode Therapeutics2.8413 of 5 stars$0.30+10.1%$10.00+3,233.3%-99.9%$7.00MN/A0.009News CoverageHigh Trading VolumeOMGAOmega Therapeutics1.9007 of 5 stars$0.13-21.8%$9.20+7,260.0%-95.0%$6.92M$8.10M-0.09120Gap UpINDPIndaptus Therapeutics3.5195 of 5 stars$0.46-3.1%$8.50+1,728.4%-76.7%$6.71MN/A-0.276Short Interest ↓Negative NewsAIMAIM ImmunoTech1.6833 of 5 stars$0.09-22.3%$2.75+2,908.8%-76.6%$6.61M$170,000.00-0.1920Gap DownHigh Trading VolumeAPLMApollomics2.0676 of 5 stars$5.91-0.7%$200.00+3,284.1%-85.0%$6.57M$1.22M0.0045Gap UpSLXNSilexion TherapeuticsN/A$0.72-3.8%$5.00+592.8%N/A$6.52MN/A0.00N/A Related Companies and Tools Related Companies CYCN Competitors BFRI Competitors ADXN Competitors MYNZ Competitors RNAZ Competitors OMGA Competitors INDP Competitors AIM Competitors APLM Competitors SLXN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VCNX Stock Free VCNX Stock Alerts